NCT07151391View on ClinicalTrials.gov

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

PHASE2RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

September 3, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Neuroendocrine TumorsGynecologic Cancer
Interventions
DRUG

Guarana

500 mg oral medication daily

DRUG

Placebo

Oral medication daily

Trial Locations (1)

84112

RECRUITING

Huntsman Cancer Institute at University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT07151391 - The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue) | Biotech Hunter | Biotech Hunter